Longevity Supplements: A Reality Check
Key takeaways
- NMN, resveratrol and peers lack human health-span proof.
- Rapamycin is experimental, prescription-grade territory.
- Proven longevity tools remain lifestyle-shaped and mostly free.
- Finish the boring checklist before funding a stack.
The longevity-supplement market is booming on the strength of mouse studies and podcast enthusiasm. A calm reading of human evidence suggests keeping your wallet closer.
The hyped shelf
NAD-boosters like NMN and NR raise blood markers in humans; meaningful human health-span outcomes remain unproven. Resveratrol's famous promise faded in human trials. Rapamycin extends mouse lifespan and is prescription-only with real risks, human anti-aging use is experimental. The pattern: exciting biology, absent human endpoints, confident marketing.
What has actual human support
Unfashionable answers: vitamin D when deficient, omega-3 for those who never eat fish, and creatine, better known for muscle, showing broader promise. Mostly, the interventions with proven human mortality effects are free: exercise, not smoking, sleep, diet quality, social connection, blood pressure control. No capsule approaches their effect sizes.
A rational stance
Curiosity is fine; budgets and expectations should match evidence. Before any longevity stack, complete the boring checklist: fitness, strength, sleep, diet, connection, screenings. Anyone selling certainty in this field is selling ahead of the science, and the field itself says so.
This article is for general informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your individual situation, and never start or stop a medication without your doctor. See our Medical Disclaimer.